Akelos, Inc.

Form D Filings

Location
New York, NY
Industry Group
Biotechnology
Related People
Steven Fox
Entity Type
Corporation
CIK
0001760186
All SEC Filings
View on sec.gov
Date Filed Security Types Total Amount Sold Total Offering Amount Remaining First Sale Signed Form SEC Link
3/16/2026 Equity, Debt, Option to Acquire $1,486,000 Indefinite Indefinite 3/9/2026 3/16/2026 D 000176018626000005
10/28/2022 Equity $5,500 $14,000,000 $13,994,500 10/21/2022 10/28/2022 D 000110465922112470
2/5/2019 Equity $25,000 $3,000,000 $2,975,000 1/31/2019 2/5/2019 D 000114420419004979
11/28/2018 Equity $295,000 $295,000 $0 10/23/2018 11/27/2018 D 000114420418061812